Dr. McCann is Associate Director of the Division of Therapeutics and Medical Consequences at NIDA. He received a B.S. in Pharmacy (1981) from the Albany College of Pharmacy and his Ph.D. (1988) from the Department of Pharmacology and Experimental Therapeutics at the State University of New York at Buffalo. He conducted his postdoctoral research at the NIDA Intramural Research Program in Baltimore, MD. In his current position, his primary responsibility is to facilitate the discovery and development of medications to treat substance use disorders through oversight of the Division’s contract program and by establishing NIDA/private sector collaborations.